Indiana University Indianapolis Richard M. Fairbanks School of Public Health, 714 N. Senate Ave, Indianapolis, IN 46202, USA; Center for Health Policy, Indiana University Purdue University - Indianapolis, 714 N. Senate Ave, Indianapolis, IN 46202, USA; Georgia State University, Department of Sociology, 33 Peachtree Center Ave SE, Langdale Hall Suite 1061, Atlanta, GA 30303, USA.
Indiana University Indianapolis Richard M. Fairbanks School of Public Health, 714 N. Senate Ave, Indianapolis, IN 46202, USA; Center for Health Policy, Indiana University Purdue University - Indianapolis, 714 N. Senate Ave, Indianapolis, IN 46202, USA; Georgia State University, Department of Sociology, 33 Peachtree Center Ave SE, Langdale Hall Suite 1061, Atlanta, GA 30303, USA.
Res Social Adm Pharm. 2017 Nov;13(6):1167-1174. doi: 10.1016/j.sapharm.2016.12.002. Epub 2016 Dec 12.
Prescription drug abuse is epidemic in the United States (US). To help address the problem, most states operate prescription drug monitoring programs (PDMPs). PDMPs are designed to monitor and help control the distribution of controlled therapeutic medications and to assist prescribers and dispensers in making informed clinical decisions. To this end, PDMPs rely on timely and accurate data submission, as well as review of the data. Consequently, provider acceptance of these systems is essential to maximize their effectiveness.
This article explores licensed prescribers' and dispensers' opinions regarding prescription drug monitoring.
The study surveyed licensed prescribers and dispensers about their experiences and views on drug monitoring, prescribing and dispensing practices, and on prescription drug abuse in general. Two open-ended questions were posed as part of a larger, end-user survey. The analysis culled thematically-coded excerpts to these two questions.
Respondents offered a range of comments that unearthed important disagreements among prescribers and dispensers over the administration and ethics pertaining to PDMPs. At the same time, some respondents suggested means to enhance PDMPs functionality.
Attending to and rectifying providers' views, while considering their improvement suggestions may boost PDMPs effectiveness by maximizing buy-in and utilization. The potential speaks to advancing a tool that intends to help address alarming rates of prescription drug abuse.
处方药滥用在美国（美国）泛滥成灾。为帮助解决这一问题，大多数州都设有处方药监测计划（PDMP）。PDMP 的设计目的是监测和帮助控制受控治疗药物的分发，并协助处方者和配药者做出明智的临床决策。为此，PDMP 依赖于及时和准确的数据提交以及数据审查。因此，提供者对这些系统的接受程度对于最大限度地提高其效率至关重要。
本文探讨了持照处方者和配药者对处方药监测的看法。
这项研究调查了持照处方者和配药者，了解他们在药物监测、处方和配药实践方面的经验和看法，以及一般的处方药滥用情况。作为更大的最终用户调查的一部分，提出了两个开放式问题。分析从这两个问题中提取了主题编码的摘录。
受访者提出了一系列意见，这些意见揭示了处方者和配药者在 PDMP 管理和伦理方面存在的重要分歧。与此同时，一些受访者提出了增强 PDMP 功能的方法。
关注和纠正提供者的观点，同时考虑他们的改进建议，可能会通过最大限度地提高购买和使用来提高 PDMP 的效率。这种潜力表明，可以推进一种旨在帮助解决令人震惊的处方药滥用率的工具。
Zotero 插件